A public petition calling for looser restrictions on the National Health Insurance (NHI)-covered medication for treating inflammatory bowel disease (IBD) reached the 5,000-signature threshold ...

Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...

Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips. Click to read why ABBV is a Hold.

Rinvoq is used to treat rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.

Icotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between ...

Rinvoq is a prescription drug used to treat rheumatoid arthritis and other autoimmune conditions. Learn about dosages, form, strengths, and more.

The Motley Fool. DATE Wednesday, July 16, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...